🇬🇧 UMECLIDINIUM BROMIDE in United Kingdom

UMECLIDINIUM BROMIDE (UMECLIDINIUM BROMIDE) regulatory status in United Kingdom.

Marketing authorisation

MHRA

  • Local brand name: Incruse Ellipta (previously Incruse)
  • Status: approved

UMECLIDINIUM BROMIDE in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is UMECLIDINIUM BROMIDE approved in United Kingdom?

Yes. MHRA has authorised it.

Who is the marketing authorisation holder for UMECLIDINIUM BROMIDE in United Kingdom?

Marketing authorisation holder not available in our data.